The UNMC Eppley Cancer Center is an NCI-designated matrix Clinical Cancer Center at the University of Nebraska Medical Center (UNMC) conducting a wide range of basic, clinical, translational and population science cancer research. The Cancer Center Director reports directly to the Chancellor of UNMC, and also serves as Director of the Eppley Institute for Cancer Research, a multidisciplinary basic cancer research institute with 30 faculty. NCI-defined peer-reviewed funding for the Cancer Center is currently $23.93 million (annual direct costs), a 2.2 fold increase since 1999, with $18.5 million from NIH (2.4 fold increase since 1999) and $5.99 million from NCI (25% increase). Since the last review, the Cancer Center has pursued vigorous, but strategic, recruitment resulting in 35 new cancer research faculty (22 basic science and 13 clinical/translational researchers) adding significant strength in several key research areas including cancer genetics, animal models, DNA repair, cell signaling, and structural biology. The Cancer Center continues to enjoy outstanding support from the state of Nebraska and UNMC. In 2003, state and institutional support to the Cancer Center was $13.95 million. State support provided resources for faculty recruitment and shared resource enhancements, including a new 600 MHz NMR, a gene array facility, an X-ray crystallography facility, and upgrades to the animal facility. A new UNMC 286,000 sq ft research building (to open 2/04) will allow consolidation of prostate cancer, cancer genetics and drug delivery research programs. In 2003, the Cancer Center was also assigned an additional 43,000 sq ft of research space to allow continued growth, bringing the total amount of space under the authority of the Director to 200,000 sq ft. The Cancer Center has three dynamic research programs: 1) Cancer Genes and Molecular Regulation; 2) Molecular and Biochemical Etiology of Cancer; and 3) Experimental Therapeutics. Translational research is facilitated through several multidisciplinary disease-oriented working groups including breast cancer, prostate cancer, pancreatic cancer, and hematological malignancies. The Cancer Center also supports fourteen shared resources: Animal Care, Bioinformatics, Biostatistics, Cell Analysis, Clinical Trials Office, Confocal Microscopy, Histology, Laboratory Support, Mass Spectrometry, Molecular Biology, Monoclonal Antibody, Nuclear Magnetic Resonance, Safety, and Tissue Procurement.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA036727-22S1
Application #
7292986
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ptak, Krzysztof
Project Start
1997-09-05
Project End
2009-07-31
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
22
Fiscal Year
2006
Total Cost
$170,863
Indirect Cost
Name
University of Nebraska Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
168559177
City
Omaha
State
NE
Country
United States
Zip Code
68198
Robb, Caroline M; Kour, Smit; Contreras, Jacob I et al. (2018) Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget 9:5216-5232
Ouellette, Scot P; Messerli, Parker R; Wood, Nicholas A et al. (2018) Characterization of Chlamydial Rho and the Role of Rho-Mediated Transcriptional Polarity during Interferon Gamma-Mediated Tryptophan Limitation. Infect Immun 86:
Attri, Kuldeep S; Mehla, Kamiya; Shukla, Surendra K et al. (2018) Microscale Gene Expression Analysis of Tumor-Associated Macrophages. Sci Rep 8:2408
Souchek, Joshua J; Wojtynek, Nicholas E; Payne, William M et al. (2018) Hyaluronic acid formulation of near infrared fluorophores optimizes surgical imaging in a prostate tumor xenograft. Acta Biomater 75:323-333
Wipfler, Kristin; Cornish, Adam S; Guda, Chittibabu (2018) Comparative molecular characterization of typical and exceptional responders in glioblastoma. Oncotarget 9:28421-28433
Saxena, Ashima; Belinskaya, Tatyana; Schopfer, Lawrence M et al. (2018) Characterization of butyrylcholinesterase from porcine milk. Arch Biochem Biophys 652:38-49
Murthy, Divya; Attri, Kuldeep S; Singh, Pankaj K (2018) Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics. Front Physiol 9:335
Leiferman, Amy; Shu, Jiang; Grove, Ryan et al. (2018) A diet defined by its content of bovine milk exosomes and their RNA cargos has moderate effects on gene expression, amino acid profiles and grip strength in skeletal muscle in C57BL/6 mice. J Nutr Biochem 59:123-128
Khadge, Saraswoti; Sharp, John Graham; McGuire, Timothy R et al. (2018) Immune regulation and anti-cancer activity by lipid inflammatory mediators. Int Immunopharmacol 65:580-592
Cserhati, Matyas F; Mooter, Mary-Ellen; Peterson, Lauren et al. (2018) Motifome comparison between modern human, Neanderthal and Denisovan. BMC Genomics 19:472

Showing the most recent 10 out of 1372 publications